1 to 10 of 2,259 literature results

• When and how should treatment be started in Parkinson disease?

  The questions of when and how to start treatment for Parkinson disease (PD) remain extremely challenging. A variety of treatment- and patient-related …

  Authors: Anthony E Lang

  Source: Neurology. 2009 Feb 17

  View Full Text

• A phylogeny-driven genomic encyclopaedia of Bacteria and Archaea.

  Sequencing of bacterial and archaeal genomes has revolutionized our understanding of the many roles played by microorganisms. There are now nearly 1,0…

  Authors: Dongying Wu, Philip Hugenholtz, Konstantinos Mavromatis, Rüdiger Pukall, Eileen Dalin, Natalia N Ivanova, Victor Kunin, Lynne Goodwin, Martin Wu, Brian J Tindall,…

  Source: Nature. 2009 Dec 24

  View Full Text

• The progression of Parkinson disease: a hypothesis.

  Recent neuropathologic studies suggest that Parkinson disease (PD) does not begin in the substantia nigra compacta (SNc) but only involves this region…

  Authors: Anthony E Lang

  Source: Neurology. 2007 Mar 20

  View Full Text

• Dopaminergic transplantation for Parkinson's disease: current status and future prospects.

  Cell-based therapies that involve transplantation into the striatum of dopaminergic cells have attracted considerable interest as possible treatments …

  Authors: C Warren Olanow, Jeffrey H Kordower, Anthony E Lang, Jose A Obeso

  Source: Annals of neurology. 2009 Nov

  View Full Text

• Mangrovibacter plantisponsor gen. nov., sp. nov., a nitrogen-fixing bacterium isolated from a mangrove-associated wild rice (Porteresia coarctata Tateoka).

  A facultatively anaerobic, nitrogen-fixing bacterium, strain MSSRF40(T), was isolated from roots of mangrove-associated wild rice (Porteresia coarctat…

  Authors: N Rameshkumar, Elke Lang, Sudha Nair

  Source: International journal of systematic and evolutionary microbiology. 2010 Jan

  View Full Text

• Interface between tauopathies and synucleinopathies: a tale of two proteins.

  Neurodegenerative diseases are often classified based on the abnormal accumulation of synuclein or tau. Traditionally, these disorders have been viewe…

  Authors: Wendy R Galpern, Anthony E Lang

  Source: Annals of neurology. 2006 Mar

  View Full Text

• Psychogenic movement disorders.

  PURPOSE OF REVIEW: This review summarizes the progress made in the area of psychogenic movement disorders (PMDs) over the past 2 years, and a simplifi…

  Authors: Amitabh Gupta, Anthony E Lang

  Source: Current opinion in neurology. 2009 Aug

  View Full Text

• Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons.

  Animal studies suggest that rapid eye movement (REM) sleep is governed by the interaction of REM-promoting and REM-inhibiting nuclei in the pontomesen…

  Authors: Andrew S Lim, Elena Moro, Andres M Lozano, Clement Hamani, Jonathan O Dostrovsky, William D Hutchison, Anthony E Lang, Richard A Wennberg, Brian J Murray

  Source: Annals of neurology. 2009 Jul

  View Full Text

• Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells.

  PURPOSE: Pathogenesis of diabetic macular edema is driven by deregulated expression of VEGF. A study of long-term exposure of immortalized bovine reti…

  Authors: Heidrun L Deissler, Helmut Deissler, Gabriele E Lang

  Source: Investigative ophthalmology & visual science. 2010 Jan

  View Full Text

• Impaired presynaptic inhibition in the motor cortex in Parkinson disease.

  OBJECTIVE: Intracortical inhibition in the motor cortex may be measured with short interval intracortical inhibition (SICI), likely mediated by GABA(A…

  Authors: J Chu, A Wagle-Shukla, C Gunraj, A E Lang, R Chen

  Source: Neurology. 2009 Mar 3

  View Full Text